Biomea Non Operating Income Net Other from 2010 to 2026
| BMEA Stock | USD 1.32 0.04 3.13% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 1.6 M | Current Value 1.4 M | Quarterly Volatility 95.5 K |
Check Biomea Fusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomea Fusion's main balance sheet or income statement drivers, such as Net Interest Income of 6.8 M, Interest Income of 6.8 M or Depreciation And Amortization of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.57. Biomea financial statements analysis is a perfect complement when working with Biomea Fusion Valuation or Volatility modules.
Biomea | Non Operating Income Net Other | Build AI portfolio with Biomea Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:Check out the analysis of Biomea Fusion Correlation against competitors. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. Projected growth potential of Biomea fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biomea Fusion assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Biomea Fusion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Biomea Fusion's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Biomea Fusion's market price to deviate significantly from intrinsic value.
It's important to distinguish between Biomea Fusion's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biomea Fusion should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Biomea Fusion's market price signifies the transaction level at which participants voluntarily complete trades.